{"messages":[{"status":"ok","cursor":"8760","count":30,"total":9467}], "collection":[{"rel_doi":"10.1101\/2020.03.18.20037473","rel_title":"Now-casting the COVID-19 epidemic: The use case of Japan, March 2020","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.18.20037473","rel_abs":"Background Reporting delays in disease surveillance impair the ability to assess the current dynamic of an epidemic. In continuously updated epidemic curves, case numbers for the most recent epidemic week or day usually appear to be lower than the previous, suggesting a decline of the epidemic. In reality, the epidemic curve may still be on the rise, because reporting delay prevents the most recent cases to appear in the case count. In context of the COVID-19 epidemic and for countries planning large international gatherings, such as the Summer Olympic Games in Japan 2020, the ability to assess the actual stage of an epidemic is of outmost importance. Methods We applied now-casting onto COVID-19 data provided by the nCoV-2019 Data Working Group to evaluate the .true count of cases, by taking into account reporting delays occurring between date of symptom onset and date of confirmation. Findings We calculated a decrease of reporting delay, from a median delay of ten days in calendar week four 2020 to six days in calendar week eight, resulting in an overall mean of 4.3 days. The confidence intervals of the now-casting indicated an increase of cases in the last reporting days, while case country in that same time period suggested a decline. Interpretation As a specific use case this tool may be of particular value for the challenging risk assessment and risk communication in the context of the Summer Olympic Games in Japan 2020 and similar situations elsewhere.","rel_num_authors":3,"rel_authors":[{"author_name":"Stephan Gloeckner","author_inst":"Department of Epidemiology, Helmholtz Center for Infection Research"},{"author_name":"Gerard Krause","author_inst":"Department of Epidemiology, Helmholtz Centre for Infection Research"},{"author_name":"Michael Hoehle","author_inst":"Department of Mathematics, Stockholm University"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.03.19.20038950","rel_title":"A model for COVID-19 prediction in Iran based on China parameters","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.19.20038950","rel_abs":"Background: The rapid spread of COVID-19 virus from China to other countries and outbreaks of disease require an epidemiological analysis of the disease in the shortest time and an increased awareness of effective interventions. The purpose of this study was to estimate the COVID-19 epidemic in Iran based on the SIR model. The results of the analysis of the epidemiological data of Iran from January 22 to March 8, 2020 were investigated and the prediction was made until March 29, 2020. Methods: By estimating the three parameters of time-dependent transmission rate, time-dependent recovery rate, and time-dependent mortality rate from Covid-19 outbreak in China, and using the number of Covid-19 infections in Iran, we predicted the number of patients for the next month in Iran. Each of these parameters was estimated using GAM models. All analyses were conducted in R software using the mgcv package. Findings: On average, 925 people with COVID-19 are expected to be infected daily in Iran. The epidemic peaks within one week (15.03.2020 to 03.21.2020) and reaches its highest point on 03.18.2020 with 1126 infected cases. Conclusion: The most important point is to emphasize the timing of the epidemic peak, hospital readiness, government measures and public readiness to reduce social contact.","rel_num_authors":5,"rel_authors":[{"author_name":"Bushra Zareie","author_inst":"Hamadan University of Medical Sciences, Hamadan, Iran"},{"author_name":"Amin Roshani","author_inst":"Razi University, Kermanshah, Iran"},{"author_name":"Mohammad Ali Mansournia","author_inst":"Tehran University of Medical Sciences, Tehran, Iran"},{"author_name":"Mohammad Aziz Rasouli","author_inst":"Kurdistan University of Medical Sciences, Sanandaj, Iran"},{"author_name":"Ghobad Moradi","author_inst":"Kurdistan University of Medical Sciences"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.03.20.20038141","rel_title":"Covid-19 dynamics in Albania: first estimates and projections","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.20.20038141","rel_abs":"The SARS-CoV-2 epidemic is one of the biggest challenges healthcare systems worldwide have ever had to face. To curb transmission many countries have adopted social distancing measures and travel restrictions. Estimating the effect of these measures in each context is challenging and requires mathematical models of the transmission dynamics. Projections for the future course of the epidemic strongly rely on model predictions and accurate representation of real-time data as they accumulate. Here I develop an SEIR modeling framework for Covid-19, to evaluate reported cases and fatalities, and to enable forecasting using evidence-based Bayesian parameter estimation. This Bayesian framework offers a tool to parametrize real-time dynamics of Covid-19 cases, and explore the effect of control as it unfolds in any setting. I apply the model to Covid-19 data from Albania, where drastic control measures were put in place already on the day of the first confirmed case. Evaluating the dynamics of reported cases 9-31 March 2020, I estimate parameters and make preliminary projections. Three weeks into the measures, Albanian data already indicate a strong signature of more than 40% transmission reduction, and lend support to a progressively increasing effect of control measures rather than a static one. In the Albanian setting, the model and data match well, projecting the peak of the outbreak may be around 5-15 April, and be contained within 300 active confirmed cases if control continues with the same trend. This framework can be used to understand the quantitative effects of different control measures in real-time, and inform adaptive intervention for success in other settings.","rel_num_authors":1,"rel_authors":[{"author_name":"Erida Gjini","author_inst":"Instituto Gulbenkian de Ciencia"},{"author_name":"Amin Roshani","author_inst":"Razi University, Kermanshah, Iran"},{"author_name":"Mohammad Ali Mansournia","author_inst":"Tehran University of Medical Sciences, Tehran, Iran"},{"author_name":"Mohammad Aziz Rasouli","author_inst":"Kurdistan University of Medical Sciences, Sanandaj, Iran"},{"author_name":"Ghobad Moradi","author_inst":"Kurdistan University of Medical Sciences"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.03.19.20038158","rel_title":"Climatic influences on the worldwide spread of SARS-CoV-2","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.19.20038158","rel_abs":"The rapid global spread of the novel, pathogenic, SARS-CoV-2 causing the severe acute respiratory disease COVID-19, becomes a major health problem worldwide and pose the need for international predictive programs. Given the lack of both specific drugs and an efficient preventive vaccine, the expectation that SARS-CoV-2 transmission rate might decrease in temperate regions during summer, dominated the social scene. Here, we attempted a prediction of the worldwide spread of the infections based on climatic data, expressed by 19 bioclimatic variables. The calculated probability maps shown that potential areas of infection follow a shift from the Tropical to Temperate and Mediterranean Bioclimatic regions, and back to the Tropics again. Maps show an increased probability of infections in Europe, followed by an expansion covering areas of the Middle East and Northern Africa, as well as Eastern coastal areas of North America, South-Eastern coastal areas of Latin America and two areas of Southern Australia, and later return to areas of Southeastern Asia, in a manner similar to that of influenza strains (H3N2). Our approach may therefore be of value for the worldwide spread of SARS-CoV-2, suggesting an optimistic scenario of asynchronous seasonal global outbreaks, like other viral respiratory diseases. Consequently, we suggest the incorporation of a climatic impact in the design and implementation of public health policies. Maps of our model are available (constantly updated up to the saturation of the model) at: https:\/\/navaak.shinyapps.io\/CVRisk\/.","rel_num_authors":4,"rel_authors":[{"author_name":"Michail Bariotakis","author_inst":"Institute of Biological and Medical Imaging, Helmholtz Zentrum Munchen, Neuherberg, Germany"},{"author_name":"George Sourvinos","author_inst":"Laboratory of Clinical Virology, School of Medicine, University of Crete"},{"author_name":"Elias Castanas","author_inst":"Laboratory of Experimental Endocrinology, School of Medicine, University of Crete"},{"author_name":"Stergios A Pirintsos","author_inst":"Department of Biology, University of Crete"},{"author_name":"Ghobad Moradi","author_inst":"Kurdistan University of Medical Sciences"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.03.19.20037945","rel_title":"Insignificant effect of counter measure for coronavirus infectious disease -19 in Japan","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.19.20037945","rel_abs":"Background: To control the COVID-19 outbreak in Japan, sports and entertainment events were canceled and schools were closed throughout Japan from February 26 through March 19. That policy has been designated as voluntary event cancellation and school closure (VECSC). Object: This study assesses VECSC effectiveness based on predicted outcomes. Method: A simple susceptible-infected-recovery model was applied to data of patients with symptoms in Japan during January 14 through March 25. The respective reproduction numbers were estimated before VECSC (R), during VECSC (Re), and after VECSC (Ra). Results: Results suggest R before VECSC as 1.987 [1.908, 2.055], Re during VECSC as 1.122 [0.980, 1.260], and Ra after VECSC as 3.086 [2.529, 3.739]. Discussion and Conclusion: Results demonstrated that VECSC can reduce COVID-19 infectiousness considerably, but the value of R rose to exceed 2.5 after VECSC.","rel_num_authors":4,"rel_authors":[{"author_name":"Yoshiyuki Sugishita","author_inst":"National Institute of Infectious Diseases, Tokyo, Japan"},{"author_name":"Junko Kurita","author_inst":"Department of Nursing , Tokiwa University, Ibaraki, Japan"},{"author_name":"Tamie Sugawara","author_inst":"National Institute of Infectious Diseases, Tokyo, Japan"},{"author_name":"Yasushi Ohkusa","author_inst":"National Institute of Infectious Diseases, Tokyo, Japan"},{"author_name":"Ghobad Moradi","author_inst":"Kurdistan University of Medical Sciences"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.03.20.20038679","rel_title":"Screening and managing of suspected or confirmed novel coronavirus (COVID-19) patients: experiences from a tertiary hospital outside Hubei province","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.20.20038679","rel_abs":"Objectives: To report our experiences screening and managing patients with suspected or confirmed novel coronavirus (COVID-19) disease using a hospital-specific protocol. Design: Longitudinal cohort study. Setting: A 1,200 bed tertiary care teaching hospital in Chengdu, Sichuan, China. Participants: 802 adults presenting to hospital with concerns of having COVID-19, 1,246 inpatients and 2,531 hospital visitors. Interventions: Screening and management of patients using a hospital-specific protocol, which included fever triage, monitoring visitors and patients, emergency response, personnel training for healthcare team members, health education for patients and family, medical materials management, disinfection and wastes disposal protocols. Results: Between 23 January and 28 February 2020, 73 people were identified as having fever plus respiratory signs with\/without a history of exposure and were tested for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by our hospital lab using RT PCR. Forty-five of these 73 people were subsequently excluded based on one negative RT PCR result plus positive results to quick screening tests for flu or other respiratory viruses. The remaining 28 people received a second RT PCR test 24 h later. Three people were confirmed positive for COVID-19 based on two consecutive positive RT PCR tests whilst 25 people were excluded based on two consecutive negative tests. The three COVID-19 confirmed cases received non-critical care. There were no new infections of medical staff or new infections of other hospital inpatients. Conclusions: All three cases were detected as a result of vigilant monitoring of hospital visitors. Whilst screening out-patients presenting to a fever clinic remains important, monitoring visitors must not be overlooked.","rel_num_authors":4,"rel_authors":[{"author_name":"Hong Pu","author_inst":"West China Hospital of Sichuan University"},{"author_name":"Yujun Xu","author_inst":"West China Hospital of Sichuan University"},{"author_name":"Gordon S. Doig","author_inst":"Northern Clinical School Intensive Care Research Unit, Sydney Medical School, University of Sydney"},{"author_name":"Yan Zhou","author_inst":"West China Hospital of Sichuan University"},{"author_name":"Ghobad Moradi","author_inst":"Kurdistan University of Medical Sciences"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"public and global health"},{"rel_doi":"10.1101\/2020.03.20.20037325","rel_title":"Predicting COVID-19 malignant progression with AI techniques","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.20.20037325","rel_abs":"As COVID-19 is highly infectious, many patients can simultaneously flood into hospitals for diagnosis and treatment, which has greatly challenged public medical systems. Treatment priority is often determined by the symptom severity based on first assessment. However, clinical observation suggests that some patients with mild symptoms may quickly deteriorate. Hence, it is crucial to identify patient early deterioration to optimize treatment strategy. To this end, we develop an early-warning system with deep learning techniques to predict COVID-19 malignant progression. Our method leverages clinical data and CT scans of outpatients and achieves an AUC of 0.920 in the single-center study and an average AUC of 0.874 in the multicenter study. Moreover, our model automatically identifies crucial indicators that contribute to the malignant progression, including Troponin, Brain natriuretic peptide, White cell count, Aspartate aminotransferase, Creatinine, and Hypersensitive C-reactive protein.","rel_num_authors":15,"rel_authors":[{"author_name":"Cong Fang","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Song Bai","author_inst":"Department of Engineering Science, University of Oxford"},{"author_name":"Qianlan Chen","author_inst":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"author_name":"Yu Zhou","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Liming Xia","author_inst":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"author_name":"Lixin Qin","author_inst":"Department of Radiology, Wuhan Pulmonary Hospital"},{"author_name":"Shi Gong","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Xudong Xie","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Chunhua Zhou","author_inst":"Department of Radiology, Wuhan Pulmonary Hospital"},{"author_name":"Dandan Tu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Changzheng Zhang","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Xiaowu Liu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Weiwei Chen","author_inst":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"author_name":"Xiang Bai","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Philip H.S. Torr","author_inst":"Department of Engineering Science, University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.03.19.20034447","rel_title":"Potential biochemical markers to identify severe cases among COVID-19 patients","rel_date":"2020-03-23","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.19.20034447","rel_abs":"There is a high mortality and long hospitalization period for severe cases with 2019 novel coronavirus disease (COVID-19) pneumonia. Therefore, it makes sense to search for a potential biomarker that could rapidly and effectively identify severe cases early. Clinical samples from 28 cases of COVID-19 (8 severe cases, 20 mild cases) in Zunyi District from January 29, 2020 to February 21, 2020 were collected and otherwise statistically analysed for biochemical markers. Serum urea, creatinine (CREA) and cystatin C (CysC) concentrations in severe COVID-19 patients were significantly higher than those in mild COVID-19 patients (P<0.001), and there were also significant differences in serum direct bilirubin (DBIL), cholinesterase (CHE) and lactate dehydrogenase (LDH) concentrations between severe and mild COVID-19 patients (P<0.05). Serum urea, CREA, CysC, DBIL, CHE and LDH could be used to distinguish severe COVID-19 cases from mild COVID-19 cases. In particular, serum biomarkers, including urea, CREA, CysC, which reflect glomerular filtration function, may have some significance as potential indicators for the early diagnosis of severe COVID-19 and to distinguish it from mild COVID-19. Glomerular filtration function injury in severe COVID-19 patients should also be considered by clinicians.","rel_num_authors":7,"rel_authors":[{"author_name":"JIANLIN XIANG","author_inst":"Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China."},{"author_name":"JING WEN","author_inst":"Department of Medical Imaging, Affiliated Hospital of Zunyi Medical University, Guizhou, China."},{"author_name":"XIAOQING YUAN","author_inst":"Department of Laboratory Medicine, The Fourth People's Hospital of Zunyi city, Guizhou, China"},{"author_name":"Shun Xiong","author_inst":"School of Laboratory Medicine, Zunyi Medical University, Guizhou, China."},{"author_name":"XUE ZHOU","author_inst":"School of Laboratory Medicine, Zunyi Medical University, Guizhou, China."},{"author_name":"CHANGJIN LIU","author_inst":"The First Affiliated Hospital of Zunyi Medical University"},{"author_name":"XUN MIN","author_inst":"Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China."},{"author_name":"Xudong Xie","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Chunhua Zhou","author_inst":"Department of Radiology, Wuhan Pulmonary Hospital"},{"author_name":"Dandan Tu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Changzheng Zhang","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Xiaowu Liu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Weiwei Chen","author_inst":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"author_name":"Xiang Bai","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Philip H.S. Torr","author_inst":"Department of Engineering Science, University of Oxford"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"},{"rel_doi":"10.1101\/2020.03.21.001933","rel_title":"SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability","rel_date":"2020-03-23","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.21.001933","rel_abs":"The emergence of SARS-CoV-2 has resulted in more than 200,000 infections and nearly 9,000 deaths globally so far. This novel virus is thought to have originated from an animal reservoir, and acquired the ability to infect human cells using the SARS-CoV cell receptor hACE2. In the wake of a global pandemic it is essential to improve our understanding of the evolutionary dynamics surrounding the origin and spread of a novel infectious disease. One way theory predicts selection pressures should shape viral evolution is to enhance binding with host cells. We first assessed evolutionary dynamics in select betacoronavirus spike protein genes to predict where these genomic regions are under directional or purifying selection between divergent viral lineages at various scales of relatedness. With this analysis, we determine a region inside the receptor-binding domain with putative sites under positive selection interspersed among highly conserved sites, which are implicated in structural stability of the viral spike protein and its union with human receptor hACE2. Next, to gain further insights into factors associated with coronaviruses recognition of the human host receptor, we performed modeling studies of five different coronaviruses and their potential binding to hACE2. Modeling results indicate that interfering with the salt bridges at hot spot 353 could be an effective strategy for inhibiting binding, and hence for the prevention of coronavirus infections. We also propose that a glycine residue at the receptor binding domain of the spike glycoprotein can have a critical role in permitting bat variants of the coronaviruses to infect human cells.","rel_num_authors":4,"rel_authors":[{"author_name":"Vinicio Armijos-Jaramillo","author_inst":"Universidad de Las Americas-Quito"},{"author_name":"Justin Yeager","author_inst":"Universidad de Las Americas-Quito"},{"author_name":"Claire Muslin","author_inst":"Universidad de Las Americas-Quito"},{"author_name":"Yunierkis Perez-Castillo","author_inst":"Universidad de Las Americas-Quito"},{"author_name":"XUE ZHOU","author_inst":"School of Laboratory Medicine, Zunyi Medical University, Guizhou, China."},{"author_name":"CHANGJIN LIU","author_inst":"The First Affiliated Hospital of Zunyi Medical University"},{"author_name":"XUN MIN","author_inst":"Department of Laboratory Medicine, Affiliated Hospital of Zunyi Medical University, Guizhou, China."},{"author_name":"Xudong Xie","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Chunhua Zhou","author_inst":"Department of Radiology, Wuhan Pulmonary Hospital"},{"author_name":"Dandan Tu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Changzheng Zhang","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Xiaowu Liu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Weiwei Chen","author_inst":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"author_name":"Xiang Bai","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Philip H.S. Torr","author_inst":"Department of Engineering Science, University of Oxford"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.20.000885","rel_title":"Emergence of SARS-CoV-2 through Recombination and Strong Purifying Selection","rel_date":"2020-03-22","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.20.000885","rel_abs":"COVID-19 has become a global pandemic caused by a novel coronavirus SARS-CoV-2. Understanding the origins of SARS-CoV-2 is critical for deterring future zoonosis and for drug discovery and vaccine development. We show evidence of strong purifying selection around the receptor binding motif (RBM) in the spike gene and in other genes among bat, pangolin and human coronaviruses, indicating similar strong evolutionary constraints in different host species. We also demonstrate that SARS-CoV-2s entire RBM was introduced through recombination with coronaviruses from pangolins, possibly a critical step in the evolution of SARS-CoV-2s ability to infect humans. Similar purifying selection in different host species and frequent recombination among coronaviruses suggest a common evolutionary mechanism that could lead to new emerging human coronaviruses.\n\nOne Sentence SummaryExtensive Recombination and Strong Purifying Selection among coronaviruses from different hosts facilitate the emergence of SARS-CoV-2","rel_num_authors":9,"rel_authors":[{"author_name":"Xiaojun Li","author_inst":"Duke University"},{"author_name":"Elena E. Giorgi","author_inst":"Los Alamos National Laboratory"},{"author_name":"Manukumar Honnayakanahalli Marichann","author_inst":"Duke University"},{"author_name":"Brian Foley","author_inst":"Los Alamos National Laboratory"},{"author_name":"Chuan Xiao","author_inst":"The University of Texas at El Paso"},{"author_name":"Xiang-peng Kong","author_inst":"New York University"},{"author_name":"Yue Chen","author_inst":"Duke University"},{"author_name":"Bette Korber","author_inst":"Los Alamos National Laboratory"},{"author_name":"Feng Gao","author_inst":"Duke University"},{"author_name":"Dandan Tu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Changzheng Zhang","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Xiaowu Liu","author_inst":"HUST-HW Joint Innovation Lab"},{"author_name":"Weiwei Chen","author_inst":"Department of Radiology, Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology"},{"author_name":"Xiang Bai","author_inst":"School of Electronic Information and Communications, Huazhong University of Science and Technology"},{"author_name":"Philip H.S. Torr","author_inst":"Department of Engineering Science, University of Oxford"}],"version":"1","license":"cc_no","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.22.002386","rel_title":"A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing","rel_date":"2020-03-22","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.22.002386","rel_abs":"An outbreak of the novel coronavirus SARS-CoV-2, the causative agent of COVID-19 respiratory disease, has infected over 290,000 people since the end of 2019, killed over 12,000, and caused worldwide social and economic disruption1,2. There are currently no antiviral drugs with proven efficacy nor are there vaccines for its prevention. Unfortunately, the scientific community has little knowledge of the molecular details of SARS-CoV-2 infection. To illuminate this, we cloned, tagged and expressed 26 of the 29 viral proteins in human cells and identified the human proteins physically associated with each using affinity-purification mass spectrometry (AP-MS), which identified 332 high confidence SARS-CoV-2-human protein-protein interactions (PPIs). Among these, we identify 66 druggable human proteins or host factors targeted by 69 existing FDA-approved drugs, drugs in clinical trials and\/or preclinical compounds, that we are currently evaluating for efficacy in live SARS-CoV-2 infection assays. The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains.","rel_num_authors":98,"rel_authors":[{"author_name":"David E. Gordon","author_inst":"UCSF"},{"author_name":"Gwendolyn M. Jang","author_inst":"UCSF"},{"author_name":"Mehdi Bouhaddou","author_inst":"UCSF"},{"author_name":"Jiewei Xu","author_inst":"UCSF"},{"author_name":"Kirsten Obernier","author_inst":"UCSF"},{"author_name":"Jeffrey Z. Guo","author_inst":"UCSF"},{"author_name":"Danielle L. Swaney","author_inst":"UCSF"},{"author_name":"Tia A. Tummino","author_inst":"UCSF"},{"author_name":"Ruth Huttenhain","author_inst":"UCSF"},{"author_name":"Robyn M. Kaake","author_inst":"UCSF"},{"author_name":"Alicia L. Richards","author_inst":"UCSF"},{"author_name":"Beril Tutuncuoglu","author_inst":"UCSF"},{"author_name":"Helene Foussard","author_inst":"UCSF"},{"author_name":"Jyoti Batra","author_inst":"UCSF"},{"author_name":"Kelsey Haas","author_inst":"UCSF"},{"author_name":"Maya Modak","author_inst":"UCSF"},{"author_name":"Minkyu Kim","author_inst":"UCSF"},{"author_name":"Paige Haas","author_inst":"UCSF"},{"author_name":"Benjamin J. Polacco","author_inst":"UCSF"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by","type":"new results","category":"systems biology"},{"rel_doi":"10.1101\/2020.03.16.20036723","rel_title":"Building a COVID-19 Vulnerability Index","rel_date":"2020-03-21","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.16.20036723","rel_abs":"COVID-19 is an acute respiratory disease that has been classified as a pandemic by the World Health Organization. Information regarding this particular disease is limited, however, it is known to have high mortality rates, particularly among individuals with preexisting medical conditions. Creating models to identify individuals who are at the greatest risk for severe complications due to COVID-19 will be useful to help for outreach campaigns in mitigating the diseases worst effects. While information specific to COVID-19 is limited, a model using complications due to other upper respiratory infections can be used as a proxy to help identify those individuals who are at the greatest risk. We present the results for three models predicting such complications, with each model having varying levels of predictive effectiveness at the expense of ease of implementation.","rel_num_authors":6,"rel_authors":[{"author_name":"Dave DeCaprio","author_inst":"ClosedLoop.ai"},{"author_name":"Joseph A Gartner III","author_inst":"ClosedLoop.ai"},{"author_name":"Thadeus Burgess","author_inst":"ClosedLoop.ai"},{"author_name":"Sarthak Kothari","author_inst":"ClosedLoop.ai"},{"author_name":"Shaayaan Sayed","author_inst":"ClosedLoop.ai"},{"author_name":"Carol J McCall","author_inst":"ClosedLoop.ai"},{"author_name":"Danielle L. Swaney","author_inst":"UCSF"},{"author_name":"Tia A. Tummino","author_inst":"UCSF"},{"author_name":"Ruth Huttenhain","author_inst":"UCSF"},{"author_name":"Robyn M. Kaake","author_inst":"UCSF"},{"author_name":"Alicia L. Richards","author_inst":"UCSF"},{"author_name":"Beril Tutuncuoglu","author_inst":"UCSF"},{"author_name":"Helene Foussard","author_inst":"UCSF"},{"author_name":"Jyoti Batra","author_inst":"UCSF"},{"author_name":"Kelsey Haas","author_inst":"UCSF"},{"author_name":"Maya Modak","author_inst":"UCSF"},{"author_name":"Minkyu Kim","author_inst":"UCSF"},{"author_name":"Paige Haas","author_inst":"UCSF"},{"author_name":"Benjamin J. Polacco","author_inst":"UCSF"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.03.20.000794","rel_title":"COVID-19 Vaccine Candidates: Prediction and Validation of 174 SARS-CoV-2 Epitopes","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.20.000794","rel_abs":"The recent outbreak of SARS-CoV-2 (2019-nCoV) virus has highlighted the need for fast and efficacious vaccine development. Stimulation of a proper immune response that leads to protection is highly dependent on presentation of epitopes to circulating T-cells via the HLA complex. SARS-CoV-2 is a large RNA virus and testing of all overlapping peptides in vitro to deconvolute an immune response is not feasible. Therefore HLA-binding prediction tools are often used to narrow down the number of peptides to test. We tested 19 epitope-HLA-binding prediction tools, and using an in vitro peptide MHC stability assay, we assessed 777 peptides that were predicted to be good binders across 11 MHC allotypes. In this investigation of potential SARS-CoV-2 epitopes we found that current prediction tools vary in performance when assessing binding stability, and they are highly dependent on the MHC allotype in question. Designing a COVID-19 vaccine where only a few epitope targets are included is therefore a very challenging task. Here, we present 174 SARS-CoV-2 epitopes with high prediction binding scores, validated to bind stably to 11 HLA allotypes. Our findings may contribute to the design of an efficacious vaccine against COVID-19.","rel_num_authors":7,"rel_authors":[{"author_name":"Marek Prachar","author_inst":"Bioinformatics Centre, Department of Biology, University of Copenhagen, Copenhagen, Denmark and Center for Genomic Medicine, Copenhagen University Hospital, Cop"},{"author_name":"Sune Justesen","author_inst":"Immunitrack ApS, Copenhagen, Denmark"},{"author_name":"Daniel B Steen-Jensen","author_inst":"Immunitrack ApS, Copenhagen, Denmark"},{"author_name":"Stephan P Thorgrimsen","author_inst":"Immunitrack ApS, Copenhagen, Denmark"},{"author_name":"Erik Jurgons","author_inst":"INTAVIS Peptide Services GmbH & Co.KG, Waldhauser Str. 64 Germany-72076 Tubingen"},{"author_name":"Ole Winther","author_inst":"Department of Applied Mathematics and Computer Science, Technical University of Denmark, 2800 Kgs. Lyngby, Denmark and Bioinformatics Centre, Department of Biol"},{"author_name":"Frederik Otzen Bagger","author_inst":"Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark and UKBB Universitats-Kinderspital, Department of Biomedicine, Basel, 4031 Base"},{"author_name":"Tia A. Tummino","author_inst":"UCSF"},{"author_name":"Ruth Huttenhain","author_inst":"UCSF"},{"author_name":"Robyn M. Kaake","author_inst":"UCSF"},{"author_name":"Alicia L. Richards","author_inst":"UCSF"},{"author_name":"Beril Tutuncuoglu","author_inst":"UCSF"},{"author_name":"Helene Foussard","author_inst":"UCSF"},{"author_name":"Jyoti Batra","author_inst":"UCSF"},{"author_name":"Kelsey Haas","author_inst":"UCSF"},{"author_name":"Maya Modak","author_inst":"UCSF"},{"author_name":"Minkyu Kim","author_inst":"UCSF"},{"author_name":"Paige Haas","author_inst":"UCSF"},{"author_name":"Benjamin J. Polacco","author_inst":"UCSF"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"immunology"},{"rel_doi":"10.1101\/2020.03.20.001008","rel_title":"RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWAB USING QIAGEN RNEASY KITS OR DIRECTLY VIA OMISSION OF AN RNA EXTRACTION STEP","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.20.001008","rel_abs":"The ongoing COVID-19 pandemic has caused an unprecedented need for rapid diagnostic testing. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) recommend a standard assay that includes an RNA extraction step from a nasopharyngeal (NP) swab followed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) to detect the purified SARS-CoV-2 RNA. The current global shortage of RNA extraction kits has caused a severe bottleneck to COVID-19 testing. We hypothesized that SARS-CoV-2 RNA could be detected from NP samples via a direct RT-qPCR assay that omits the RNA extraction step altogether, and tested this hypothesis on a series of blinded clinical samples. The direct RT-qPCR approach correctly identified 92% of NP samples (n = 155) demonstrated to be positive for SARS-CoV-2 RNA by traditional clinical diagnostic RT-qPCR that included an RNA extraction. Thus, direct RT-qPCR could be a front-line approach to identify the substantial majority of COVID-19 patients, reserving a repeat test with RNA extraction for those individuals with high suspicion of infection but an initial negative result. This strategy would drastically ease supply chokepoints of COVID-19 testing and should be applicable throughout the world.","rel_num_authors":19,"rel_authors":[{"author_name":"Emily A Bruce","author_inst":"The University of Vermont"},{"author_name":"Meei-Li Huang","author_inst":"University of Washington"},{"author_name":"Garrett A Perchetti","author_inst":"University of Washington"},{"author_name":"Scott Tighe","author_inst":"The University of Vermont"},{"author_name":"Jessica J Hoffman","author_inst":"The University of Vermont"},{"author_name":"Pheobe Laaguiby","author_inst":"The University of Vermont"},{"author_name":"Diana L Gerrard","author_inst":"The University of Vermont"},{"author_name":"Arun Nalla","author_inst":"University of Washington"},{"author_name":"Yulun Wei","author_inst":"University of Washington"},{"author_name":"Alexander L Greninger","author_inst":"University of Washington"},{"author_name":"Sean A. Diehl","author_inst":"University of Vermont"},{"author_name":"David J Shirley","author_inst":"IXIS LLC"},{"author_name":"Debra G. B. Leonard","author_inst":"The University of Vermont"},{"author_name":"Christopher D. Huston","author_inst":"The University of Vermont"},{"author_name":"Beth D. Kirkpatrick","author_inst":"The University of Vermont"},{"author_name":"Julie Dragon","author_inst":"The University of Vermont"},{"author_name":"Jessica W Crothers","author_inst":"The University of Vermont"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.20.999029","rel_title":"Replication of SARS-CoV-2 in human respiratory epithelium","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.20.999029","rel_abs":"SARS-CoV-2 emerged by the end of 2019 to rapidly spread in 2020. At present, it is of utmost importance to understand the virus biology and to rapidly assess the potential of existing drugs and develop new active compounds. While some animal models for such studies are under development, most of the research is carried out in the Vero E6 cells. Here, we propose fully differentiated human airway epithelium cultures as a model for studies on the SARS-CoV-2. Further, we also provide basic characteristics of the system.","rel_num_authors":13,"rel_authors":[{"author_name":"Aleksandra Milewska","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Anna Kula-Pacurar","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Jakub Wadas","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Agnieszka Suder","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Artur Szczepanski","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Agnieszka Dabrowska","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Katarzyna Owczarek","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Marek Ochman","author_inst":"Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, the Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases,"},{"author_name":"Tomasz Stacel","author_inst":"Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, the Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases,"},{"author_name":"Zenon Rajfur","author_inst":"Institute of Physics, Faculty of Physics, Astronomy and Applied Computer Sciences, Jagiellonian University, Lojasiewicza 11, 30-348, Krakow, Poland."},{"author_name":"Pawel Piotr Labaj","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Wojciech Branicki","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Krzysztof Pyrc","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Christopher D. Huston","author_inst":"The University of Vermont"},{"author_name":"Beth D. Kirkpatrick","author_inst":"The University of Vermont"},{"author_name":"Julie Dragon","author_inst":"The University of Vermont"},{"author_name":"Jessica W Crothers","author_inst":"The University of Vermont"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_no","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.21.001586","rel_title":"Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.21.001586","rel_abs":"The ongoing pandemic of the coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2). We have performed an integrated sequence-based analysis of SARS-CoV2 genomes from different geographical locations in order to identify its unique features absent in SARS-CoV and other related coronavirus family genomes, conferring unique infection, facilitation of transmission, virulence and immunogenic features to the virus. The phylogeny of the genomes yields some interesting results. Systematic gene level mutational analysis of the genomes has enabled us to identify several unique features of the SARS-CoV2 genome, which includes a unique mutation in the spike surface glycoprotein (A930V (24351C>T)) in the Indian SARS-CoV2, absent in other strains studied here. We have also predicted the impact of the mutations in the spike glycoprotein function and stability, using computational approach. To gain further insights into host responses to viral infection, we predict that antiviral host-miRNAs may be controlling the viral pathogenesis. Our analysis reveals nine host miRNAs which can potentially target SARS-CoV2 genes. Interestingly, the nine miRNAs do not have targets in SARS and MERS genomes. Also, hsa-miR-27b is the only unique miRNA which has a target gene in the Indian SARS-CoV2 genome. We also predicted immune epitopes in the genomes","rel_num_authors":4,"rel_authors":[{"author_name":"Rahila Sardar","author_inst":"International Centre for Genetic Engineering and Biotechnology (ICGEB) and Jamia Hamdard, India"},{"author_name":"Deepshikha Satish","author_inst":"International Centre for Genetic Engineering and Biotechnology (ICGEB), India"},{"author_name":"Shweta Birla","author_inst":"International Centre for Genetic Engineering and Biotechnology (ICGEB), India"},{"author_name":"Dinesh Gupta","author_inst":"International Centre for Genetic Engineering and Biotechnology (ICGEB), India"},{"author_name":"Artur Szczepanski","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Agnieszka Dabrowska","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Katarzyna Owczarek","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Marek Ochman","author_inst":"Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, the Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases,"},{"author_name":"Tomasz Stacel","author_inst":"Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, the Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases,"},{"author_name":"Zenon Rajfur","author_inst":"Institute of Physics, Faculty of Physics, Astronomy and Applied Computer Sciences, Jagiellonian University, Lojasiewicza 11, 30-348, Krakow, Poland."},{"author_name":"Pawel Piotr Labaj","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Wojciech Branicki","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Krzysztof Pyrc","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Christopher D. Huston","author_inst":"The University of Vermont"},{"author_name":"Beth D. Kirkpatrick","author_inst":"The University of Vermont"},{"author_name":"Julie Dragon","author_inst":"The University of Vermont"},{"author_name":"Jessica W Crothers","author_inst":"The University of Vermont"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_no","type":"new results","category":"bioinformatics"},{"rel_doi":"10.1101\/2020.03.19.998724","rel_title":"All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.19.998724","rel_abs":"A recent outbreak of novel coronavirus (SARS-CoV-2), the causative agent of COVID-19, has spread rapidly all over the world. Human immunodeficiency virus (HIV) is another deadly virus and causes acquired immunodeficiency syndrome (AIDS). Rapid and early detection of these viruses will facilitate early intervention and reduce disease transmission risk. Here, we present an All-In-One Dual CRISPR-Cas12a (termed \"AIOD-CRISPR\") assay method for simple, rapid, ultrasensitive, one-pot, and visual detection of coronavirus SARS-CoV-2 and HIV virus. In our AIOD CRISPR assay, a pair of crRNAs was introduced to initiate dual CRISPR-Cas12a detection and improve detection sensitivity. The AIOD-CRISPR assay system was successfully utilized to detect nucleic acids (DNA and RNA) of SARS-CoV-2 and HIV with a sensitivity of few copies. Also, it was evaluated by detecting HIV-1 RNA extracted from human plasma samples, achieving a comparable sensitivity with real-time RT-PCR method. Thus, our method has a great potential for developing next-generation point-of-care molecular diagnostics.","rel_num_authors":4,"rel_authors":[{"author_name":"Xiong Ding","author_inst":"Univerisity of Connecticut Health Center"},{"author_name":"Kun Yin","author_inst":"University of Connecticut Health Center"},{"author_name":"Ziyue Li","author_inst":"University of Connecticut Health Center"},{"author_name":"Changchun Liu","author_inst":"University of Connecticut Health Center"},{"author_name":"Artur Szczepanski","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Agnieszka Dabrowska","author_inst":"Microbiology Department, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Katarzyna Owczarek","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Marek Ochman","author_inst":"Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, the Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases,"},{"author_name":"Tomasz Stacel","author_inst":"Department of Cardiac, Vascular and Endovascular Surgery and Transplantology, the Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases,"},{"author_name":"Zenon Rajfur","author_inst":"Institute of Physics, Faculty of Physics, Astronomy and Applied Computer Sciences, Jagiellonian University, Lojasiewicza 11, 30-348, Krakow, Poland."},{"author_name":"Pawel Piotr Labaj","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Wojciech Branicki","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Krzysztof Pyrc","author_inst":"Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland."},{"author_name":"Christopher D. Huston","author_inst":"The University of Vermont"},{"author_name":"Beth D. Kirkpatrick","author_inst":"The University of Vermont"},{"author_name":"Julie Dragon","author_inst":"The University of Vermont"},{"author_name":"Jessica W Crothers","author_inst":"The University of Vermont"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"biochemistry"},{"rel_doi":"10.1101\/2020.03.21.001628","rel_title":"Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.21.001628","rel_abs":"An outbreak of a novel coronavirus, now named SARS-CoV-2, causing respiratory disease and a [~]2% case fatality rate started in Wuhan, China in December 2019. Following unprecedented rapid global spread, the World Health Organization declared COVID-19 a pandemic on March 11, 2020. Although data on disease in humans are emerging at a steady pace, certain aspects of the pathogenesis of SARS-CoV-2 can only be studied in detail in animal models, where repeated sampling and tissue collection is possible. Here, we show that SARS-CoV-2 causes respiratory disease in infected rhesus macaques, with disease lasting 8-16 days. Pulmonary infiltrates, a hallmark of human disease, were visible in lung radiographs of all animals. High viral loads were detected in swabs from the nose and throat of all animals as well as in bronchoalveolar lavages; in one animal we observed prolonged rectal shedding. Taken together, the rhesus macaque recapitulates moderate disease observed in the majority of human cases. The establishment of the rhesus macaque as a model of COVID-19 will increase our understanding of the pathogenesis of this disease and will aid development and testing of medical countermeasures.","rel_num_authors":17,"rel_authors":[{"author_name":"Vincent Munster","author_inst":"NIAID"},{"author_name":"Friederike Feldmann","author_inst":"NIAID"},{"author_name":"Brandi Williamson","author_inst":"NIAID"},{"author_name":"Neeltje van Doremalen","author_inst":"NIAID"},{"author_name":"Lizzette Perez-Perez,","author_inst":"NIAID"},{"author_name":"Jonathan Schultz","author_inst":"NIAID"},{"author_name":"Kimberly Meade-White","author_inst":"NIAID"},{"author_name":"Atsushi Okumura","author_inst":"NIAID"},{"author_name":"Julie Callison","author_inst":"NIAID"},{"author_name":"Beniah Brumbaugh","author_inst":"NIAID"},{"author_name":"Victoria Avanzato","author_inst":"NIAID"},{"author_name":"Rebecca Rosenke","author_inst":"NIAID"},{"author_name":"Patrick Hanley","author_inst":"NIAID"},{"author_name":"Greg Saturday","author_inst":"NIAID"},{"author_name":"Dana Scott","author_inst":"NIAID"},{"author_name":"Elizabeth Fischer","author_inst":"NIAID"},{"author_name":"Emmie de Wit","author_inst":"NIAID, NIH"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc0","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.19.998179","rel_title":"Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del)","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.19.998179","rel_abs":"We present the first genetic characterization of a COVID-19 cluster in Europe using metagenomic next-generation sequencing (mNGS). Despite low viral loads, the mNGS workflow used herein allowed to characterize the whole genome sequences of SARS-CoV2 isolated from an asymptomatic patient, in 2 clinical samples collected 1 day apart. Comparison of these sequences suggests viral evolution with development of quasispecies. In addition, the present workflow identified a new deletion in nsp2 (Asp268Del) which was found in all 3 samples originating from this cluster as well as in 37 other viruses collected in England and in Netherlands, suggesting the spread of this deletion in Europe. The impact of Asp268Del on SARS-CoV-2 transmission and pathogenicity, as well as on PCR performances and anti-viral strategy should be rapidly evaluated in further studies.","rel_num_authors":14,"rel_authors":[{"author_name":"Antonin Bal","author_inst":"Hospices Civils de Lyon"},{"author_name":"Gregory Destras","author_inst":"Hospices Civils de Lyon"},{"author_name":"Alexandre Gaymard","author_inst":"Hospices Civils de Lyon"},{"author_name":"Maude Bouscambert-Duchamp","author_inst":"Hospices Civils de Lyon"},{"author_name":"Martine Valette","author_inst":"Hospices Civils de Lyon"},{"author_name":"Vanessa Escuret","author_inst":"Hospices Civils de Lyon"},{"author_name":"Emilie Frobert","author_inst":"Hospices Civils de Lyon"},{"author_name":"Genevieve Billaud","author_inst":"Hospices Civils de Lyon"},{"author_name":"Sophie Trouillet-Assant","author_inst":"Hospices Civils de Lyon"},{"author_name":"Valerie Cheynet","author_inst":"BioMerieux"},{"author_name":"Karen Brengel-Pesce","author_inst":"BioMerieux"},{"author_name":"Florence Morfin","author_inst":"Hospices Civils de Lyon"},{"author_name":"Bruno Lina","author_inst":"Hospices Civils de Lyon"},{"author_name":"Laurence Josset","author_inst":"Hospices Civils de Lyon"},{"author_name":"Dana Scott","author_inst":"NIAID"},{"author_name":"Elizabeth Fischer","author_inst":"NIAID"},{"author_name":"Emmie de Wit","author_inst":"NIAID, NIH"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.20.000141","rel_title":"COVID-19 coronavirus vaccine design using reverse vaccinology and machine learning","rel_date":"2020-03-21","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.20.000141","rel_abs":"To ultimately combat the emerging COVID-19 pandemic, it is desired to develop an effective and safe vaccine against this highly contagious disease caused by the SARS-CoV-2 coronavirus. Our literature and clinical trial survey showed that the whole virus, as well as the spike (S) protein, nucleocapsid (N) protein, and membrane protein, have been tested for vaccine development against SARS and MERS. We further used the Vaxign reverse vaccinology tool and the newly developed Vaxign-ML machine learning tool to predict COVID-19 vaccine candidates. The N protein was found to be conserved in the more pathogenic strains (SARS\/MERS\/COVID-19), but not in the other human coronaviruses that mostly cause mild symptoms. By investigating the entire proteome of SARS-CoV-2, six proteins, including the S protein and five non-structural proteins (nsp3, 3CL-pro, and nsp8-10) were predicted to be adhesins, which are crucial to the viral adhering and host invasion. The S, nsp3, and nsp8 proteins were also predicted by Vaxign-ML to induce high protective antigenicity. Besides the commonly used S protein, the nsp3 protein has not been tested in any coronavirus vaccine studies and was selected for further investigation. The nsp3 was found to be more conserved among SARS-CoV-2, SARS-CoV, and MERS-CoV than among 15 coronaviruses infecting human and other animals. The protein was also predicted to contain promiscuous MHC-I and MHC-II T-cell epitopes, and linear B-cell epitopes localized in specific locations and functional domains of the protein. Our predicted vaccine targets provide new strategies for effective and safe COVID-19 vaccine development.","rel_num_authors":4,"rel_authors":[{"author_name":"Edison Ong","author_inst":"University of Michigan"},{"author_name":"Mei U Wong","author_inst":"University of Michigan"},{"author_name":"Anthony Huffman","author_inst":"University of Michigan"},{"author_name":"Yongqun He","author_inst":"University of Michigan"},{"author_name":"Martine Valette","author_inst":"Hospices Civils de Lyon"},{"author_name":"Vanessa Escuret","author_inst":"Hospices Civils de Lyon"},{"author_name":"Emilie Frobert","author_inst":"Hospices Civils de Lyon"},{"author_name":"Genevieve Billaud","author_inst":"Hospices Civils de Lyon"},{"author_name":"Sophie Trouillet-Assant","author_inst":"Hospices Civils de Lyon"},{"author_name":"Valerie Cheynet","author_inst":"BioMerieux"},{"author_name":"Karen Brengel-Pesce","author_inst":"BioMerieux"},{"author_name":"Florence Morfin","author_inst":"Hospices Civils de Lyon"},{"author_name":"Bruno Lina","author_inst":"Hospices Civils de Lyon"},{"author_name":"Laurence Josset","author_inst":"Hospices Civils de Lyon"},{"author_name":"Dana Scott","author_inst":"NIAID"},{"author_name":"Elizabeth Fischer","author_inst":"NIAID"},{"author_name":"Emmie de Wit","author_inst":"NIAID, NIH"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by","type":"new results","category":"bioinformatics"},{"rel_doi":"10.1101\/2020.03.18.20035816","rel_title":"Development and utilization of an intelligent application for aiding COVID-19 diagnosis","rel_date":"2020-03-21","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.18.20035816","rel_abs":"On basis of laboratory examinations indicators from a total of 620 samples, a machine learning-based diagnosis model was developed, and subsequently implemented as a COVID-19 diagnosis aid APP. External validation showed satisfiable model prediction performance (i.e., AUC= 0.872) which guarantees the promising use of this tool for extensive screening.","rel_num_authors":13,"rel_authors":[{"author_name":"Zirui Meng","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Minjin Wang","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Huan Song","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Shuo Guo","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Yanbing Zhou","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Weimin Li","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Yongzhao Zhou","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Mengjiao Li","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Xingbo Song","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Yi Zhou","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Qingfeng Li","author_inst":"Public Health Clinical Center of Chengdu"},{"author_name":"Xiaojun Lu","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Binwu Ying","author_inst":"West China Hospital of Sichuan University"},{"author_name":"Laurence Josset","author_inst":"Hospices Civils de Lyon"},{"author_name":"Dana Scott","author_inst":"NIAID"},{"author_name":"Elizabeth Fischer","author_inst":"NIAID"},{"author_name":"Emmie de Wit","author_inst":"NIAID, NIH"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_no","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.03.19.999318","rel_title":"The first-in-class peptide binder to the SARS-CoV-2 spike protein","rel_date":"2020-03-20","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.19.999318","rel_abs":"Coronavirus disease 19 (COVID-19) is an emerging global health crisis. With over 7 million confirmed cases to date, this pandemic continues to expand, spurring research to discover vaccines and therapies. SARS-CoV-2 is the novel coronavirus responsible for this disease. It initiates entry into human cells by binding to angiotensin-converting enzyme 2 (ACE2) via the receptor binding domain (RBD) of its spike protein (S). Disrupting the SARS-CoV-2-RBD binding to ACE2 with designer drugs has the potential to inhibit the virus from entering human cells, presenting a new modality for therapeutic intervention. Peptide-based binders are an attractive solution to inhibit the RBD-ACE2 interaction by adequately covering the extended protein contact interface. Using molecular dynamics simulations based on the recently solved cryo-EM structure of ACE2 in complex with SARS-CoV-2-RBD, we observed that the ACE2 peptidase domain (PD) 1 helix is important for binding SARS-CoV-2-RBD. Using automated fast-flow peptide synthesis, we chemically synthesized a 23-mer peptide fragment of the ACE2 PD 1 helix (SBP1) composed entirely of proteinogenic amino acids. Chemical synthesis of SBP1 was complete in 1.5 hours, and after work up and isolation >20 milligrams of pure material was obtained. Bio-layer interferometry (BLI) revealed that SBP1 associates with micromolar affinity to insect-derived SARS-CoV-2-RBD protein obtained from Sino Biological. Association of SBP1 was not observed to an appreciable extent to HEK cell-expressed SARS-CoV-2-RBD proteins and insect-derived variants acquired from other vendors. Moreover, competitive BLI assays showed SBP1 does not outcompete ACE2 binding to Sino Biological insect-derived SARS-CoV-2-RBD. Further investigations are ongoing to gain insight into the molecular and structural determinants of the variable binding behavior to different SARS-CoV-2-RBD protein variants.","rel_num_authors":6,"rel_authors":[{"author_name":"Genwei Zhang","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Sebastian Pomplun","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Alexander Robert Loftis","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Xuyu Tan","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Andrei Loas","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Bradley L. Pentelute","author_inst":"Massachusetts Institute of Technology"},{"author_name":"Yongzhao Zhou","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Mengjiao Li","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Xingbo Song","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Yi Zhou","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Qingfeng Li","author_inst":"Public Health Clinical Center of Chengdu"},{"author_name":"Xiaojun Lu","author_inst":"West China Hospital, Sichuan University"},{"author_name":"Binwu Ying","author_inst":"West China Hospital of Sichuan University"},{"author_name":"Laurence Josset","author_inst":"Hospices Civils de Lyon"},{"author_name":"Dana Scott","author_inst":"NIAID"},{"author_name":"Elizabeth Fischer","author_inst":"NIAID"},{"author_name":"Emmie de Wit","author_inst":"NIAID, NIH"},{"author_name":"Keith R Jerome","author_inst":"University of WA\/Fred Hutchinson Cancer Research Center"},{"author_name":"Jason W Botten","author_inst":"The University of Vermont"},{"author_name":"Hannes Braberg","author_inst":"UCSF"},{"author_name":"Jacqueline M. Fabius","author_inst":"UCSF"},{"author_name":"Manon Eckhardt","author_inst":"UCSF"},{"author_name":"Margaret Soucheray","author_inst":"UCSF"},{"author_name":"Melanie J. Bennett","author_inst":"UCSF"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"bioengineering"},{"rel_doi":"10.1101\/2020.03.19.997890","rel_title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus","rel_date":"2020-03-20","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.19.997890","rel_abs":"Coronaviruses (CoVs) traffic frequently between species resulting in novel disease outbreaks, most recently exemplified by the newly emerged SARS-CoV-2. Herein, we show that the ribonucleoside analog {beta}-D-N4-hydroxycytidine (NHC, EIDD-1931) has broad spectrum antiviral activity against SARS-CoV 2, MERS-CoV, SARS-CoV, and related zoonotic group 2b or 2c Bat-CoVs, as well as increased potency against a coronavirus bearing resistance mutations to another nucleoside analog inhibitor. In mice infected with SARS-CoV or MERS-CoV, both prophylactic and therapeutic administration of EIDD-2801, an orally bioavailable NHC-prodrug (b-D-N4-hydroxycytidine-5-isopropyl ester), improved pulmonary function, and reduced virus titer and body weight loss. Decreased MERS-CoV yields in vitro and in vivo were associated with increased transition mutation frequency in viral but not host cell RNA, supporting a mechanism of lethal mutagenesis. The potency of NHC\/EIDD-2801 against multiple coronaviruses, its therapeutic efficacy, and oral bioavailability in vivo, all highlight its potential utility as an effective antiviral against SARS-CoV-2 and other future zoonotic coronaviruses.","rel_num_authors":24,"rel_authors":[{"author_name":"Timothy P Sheahan","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Amy C Sims","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Shuntai Zhou","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Collin Hill","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Sarah R Leist","author_inst":"University of North Carolina"},{"author_name":"Alexandra Schaefer","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Maria Agostini","author_inst":"Vanderbilt University"},{"author_name":"Andrea Pruijssers","author_inst":"Vanderbilt University"},{"author_name":"Ariane J Brown","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Gregory Bluemling","author_inst":"Emory University"},{"author_name":"Michael Natchus","author_inst":"Emory University"},{"author_name":"Manohar Saindane","author_inst":"Emory University"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.14.992156","rel_title":"Potential Neutralizing Antibodies Discovered for Novel Corona Virus Using Machine Learning","rel_date":"2020-03-20","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.14.992156","rel_abs":"The fast and untraceable virus mutations take lives of thousands of people before the immune system can produce the inhibitory antibody. Recent outbreak of novel coronavirus infected and killed thousands of people in the world. Rapid methods in finding peptides or antibody sequences that can inhibit the viral epitopes of COVID-19 will save the life of thousands. In this paper, we devised a machine learning (ML) model to predict the possible inhibitory synthetic antibodies for Corona virus. We collected 1933 virus-antibody sequences and their clinical patient neutralization response and trained an ML model to predict the antibody response. Using graph featurization with variety of ML methods, we screened thousands of hypothetical antibody sequences and found 8 stable antibodies that potentially inhibit COVID-19. We combined bioinformatics, structural biology, and Molecular Dynamics (MD) simulations to verify the stability of the candidate antibodies that can inhibit the Corona virus.","rel_num_authors":3,"rel_authors":[{"author_name":"Rishikesh Magar","author_inst":"Carnegie Mellon University"},{"author_name":"Prakarsh Yadav","author_inst":"Carnegie Mellon University"},{"author_name":"Amir Barati Farimani","author_inst":"Carnegie Mellon University"},{"author_name":"Collin Hill","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Sarah R Leist","author_inst":"University of North Carolina"},{"author_name":"Alexandra Schaefer","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Maria Agostini","author_inst":"Vanderbilt University"},{"author_name":"Andrea Pruijssers","author_inst":"Vanderbilt University"},{"author_name":"Ariane J Brown","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Gregory Bluemling","author_inst":"Emory University"},{"author_name":"Michael Natchus","author_inst":"Emory University"},{"author_name":"Manohar Saindane","author_inst":"Emory University"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"immunology"},{"rel_doi":"10.1101\/2020.03.17.995795","rel_title":"Scientometric Trends for Coronaviruses and Other Emerging Viral Infections","rel_date":"2020-03-20","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.17.995795","rel_abs":"COVID-19 is the most rapidly expanding coronavirus outbreak in the past two decades. To provide a swift response to a novel outbreak, prior knowledge from similar outbreaks is essential. Here, we study the volume of research conducted on previous coronavirus outbreaks, specifically SARS and MERS, relative to other infectious diseases by analyzing over 35 million papers from the last 20 years. Our results demonstrate that previous coronavirus outbreaks have been understudied compared to other viruses. We also show that the research volume of emerging infectious diseases is very high after an outbreak and drops drastically upon the containment of the disease. This can yield inadequate research and limited investment in gaining a full understanding of novel coronavirus management and prevention. Independent of the outcome of the current COVID-19 outbreak, we believe that measures should be taken to encourage sustained research in the field.","rel_num_authors":3,"rel_authors":[{"author_name":"Dima Kagan","author_inst":"Ben-Gurion University of the Negev"},{"author_name":"Jacob Moran-Gilad","author_inst":"Ben-Gurion University of the Negev"},{"author_name":"Michael Fire","author_inst":"Ben-Gurion University of the Negev"},{"author_name":"Collin Hill","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Sarah R Leist","author_inst":"University of North Carolina"},{"author_name":"Alexandra Schaefer","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Maria Agostini","author_inst":"Vanderbilt University"},{"author_name":"Andrea Pruijssers","author_inst":"Vanderbilt University"},{"author_name":"Ariane J Brown","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Gregory Bluemling","author_inst":"Emory University"},{"author_name":"Michael Natchus","author_inst":"Emory University"},{"author_name":"Manohar Saindane","author_inst":"Emory University"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nd","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.20.999730","rel_title":"Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs","rel_date":"2020-03-20","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.20.999730","rel_abs":"COVID-19 is an emerging infectious disease and was recently declared as a pandemic by WHO. Currently, there is no vaccine or therapeutic available for this disease. Drug repositioning represents the only feasible option to address this global challenge and a panel of 48 FDA-approved drugs that have been pre-selected by an assay of SARS-CoV was screened to identify potential antiviral drug candidates against SARS-CoV-2 infection. We found a total of 24 drugs which exhibited antiviral efficacy (0.1 M < IC50 < 10 M) against SARS-CoV-2. In particular, two FDA-approved drugs - niclosamide and ciclesonide - were notable in some respects. These drugs will be tested in an appropriate animal model for their antiviral activities. In near future, these already FDA-approved drugs could be further developed following clinical trials in order to provide additional therapeutic options for patients with COVID-19.","rel_num_authors":8,"rel_authors":[{"author_name":"Sangeun Jeon","author_inst":"Institut Pasteur Korea"},{"author_name":"Meehyun Ko","author_inst":"Institut Pasteur Korea"},{"author_name":"Jihye Lee","author_inst":"Institut Pasteur Korea"},{"author_name":"Inhee Choi","author_inst":"Institut Pasteur Korea"},{"author_name":"Soo Young Byun","author_inst":"Institut Pasteur Korea"},{"author_name":"Soonju Park","author_inst":"Institut Pasteur Korea"},{"author_name":"David Shum","author_inst":"Institut Pasteur Korea"},{"author_name":"Seungtaek Kim","author_inst":"Institut Pasteur Korea"},{"author_name":"Ariane J Brown","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Gregory Bluemling","author_inst":"Emory University"},{"author_name":"Michael Natchus","author_inst":"Emory University"},{"author_name":"Manohar Saindane","author_inst":"Emory University"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_no","type":"new results","category":"microbiology"},{"rel_doi":"10.1101\/2020.03.18.997585","rel_title":"Nucleotide Analogues as Inhibitors of SARS-CoV-2 Polymerase","rel_date":"2020-03-20","rel_site":"bioRxiv","rel_link":"https:\/\/biorxiv.org\/cgi\/content\/short\/2020.03.18.997585","rel_abs":"SARS-CoV-2, a member of the coronavirus family, is responsible for the current COVID-19 pandemic. Based on our analysis of hepatitis C virus and coronavirus replication, and the molecular structures and activities of viral inhibitors, we previously demonstrated that three nucleotide analogues inhibit the SARS-CoV RNA-dependent RNA polymerase (RdRp). Here, using polymerase extension experiments, we have demonstrated that the active triphosphate form of Sofosbuvir (a key component of the FDA approved hepatitis C drug EPCLUSA), is incorporated by SARS-CoV-2 RdRp, and blocks further incorporation. Using the same molecular insight, we selected the active triphosphate forms of three other anti-viral agents, Alovudine, AZT (an FDA approved HIV\/AIDS drug) and Tenofovir alafenamide (TAF, an FDA approved drug for HIV and hepatitis B) for evaluation as inhibitors of SARS-CoV-2 RdRp. We demonstrated the ability of these three viral polymerase inhibitors, 3-fluoro-3-deoxythymidine triphosphate, 3-azido-3-deoxythymidine triphosphate and Tenofovir diphosphate (the active triphosphate forms of Alovudine, AZT and TAF, respectively) to be incorporated by SARS-CoV-2 RdRp, where they also terminate further polymerase extension. These results offer a strong molecular basis for these nucleotide analogues to be evaluated as potential therapeutics for COVID-19.","rel_num_authors":9,"rel_authors":[{"author_name":"Minchen Chien","author_inst":"Columbia University"},{"author_name":"Thomas K. Anderson","author_inst":"University of Wisconsin-Madison"},{"author_name":"Steffen Jockusch","author_inst":"Columbia University"},{"author_name":"Chuanjuan Tao","author_inst":"Columbia University"},{"author_name":"Shiv Kumar","author_inst":"Columbia University"},{"author_name":"Xiaoxu Li","author_inst":"Columbia University"},{"author_name":"James J. Russo","author_inst":"Columbia University"},{"author_name":"Robert Kirchdoerfer","author_inst":"University of Wisconsin-Madison"},{"author_name":"Jingyue Ju","author_inst":"Columbia University"},{"author_name":"Gregory Bluemling","author_inst":"Emory University"},{"author_name":"Michael Natchus","author_inst":"Emory University"},{"author_name":"Manohar Saindane","author_inst":"Emory University"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"new results","category":"pharmacology and toxicology"},{"rel_doi":"10.1101\/2020.03.17.20037770","rel_title":"COVID-19 Progression Timeline and Effectiveness of Response-to-Spread Interventions across the United States","rel_date":"2020-03-20","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.17.20037770","rel_abs":"Motivated by the rapid upsurge of COVID-19 cases in the United States beginning March 2020, we forecast the disease spread and assess the effectiveness of containment strategies by using an estalished network-driven epidemic dynamic model. Our model is initialized using the daily counts of active and confirmed COVID-19 cases across the US. Based on our model predictions for the March 14-16 timeframe, the national epidemic peak could be expected to arrive by early June, corresponding to a daily active count of {approx} 7% of the US population, if no containment plans are implemented. Epidemic peaks are expected to arrive in the states of Washington and New York by May 21 and 25, respectively. With a modest 25% reduction in COVID-19 transmissibility via community-level interventions, the epidemic progression could be delayed by up to 34 days. Wholesale interstate traffic restriction is ineffective in delaying the epidemic outbreak, but it does desynchronize the arrival of state-wise epidemic peaks, which could potentially alleviate the burden on limited available medical resources. In addition to forecasting the arrival timeline of the state-wise epidemic peaks, we attempt at informing the optimal timing necessary to enforce community-level interventions. Our findings underscore the pressing need for preparedness and timely interventions in states with a large fraction of the vulnerable uninsured and liquid-asset-poverty populations.","rel_num_authors":3,"rel_authors":[{"author_name":"Pai Liu","author_inst":"Washington University in Saint Louis"},{"author_name":"Payton Beeler","author_inst":"Washington University in Saint Louis"},{"author_name":"Rajan K Chakrabarty","author_inst":"Washington University in Saint Louis"},{"author_name":"Chuanjuan Tao","author_inst":"Columbia University"},{"author_name":"Shiv Kumar","author_inst":"Columbia University"},{"author_name":"Xiaoxu Li","author_inst":"Columbia University"},{"author_name":"James J. Russo","author_inst":"Columbia University"},{"author_name":"Robert Kirchdoerfer","author_inst":"University of Wisconsin-Madison"},{"author_name":"Jingyue Ju","author_inst":"Columbia University"},{"author_name":"Gregory Bluemling","author_inst":"Emory University"},{"author_name":"Michael Natchus","author_inst":"Emory University"},{"author_name":"Manohar Saindane","author_inst":"Emory University"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"infectious diseases"},{"rel_doi":"10.1101\/2020.03.16.20035014","rel_title":"Evaluation of Nucleocapsid and Spike Protein-based ELISAs for detecting antibodies against SARS-CoV-2","rel_date":"2020-03-20","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.16.20035014","rel_abs":"Background: At present, PCR-based nucleic acid detection cannot meet the demands for coronavirus infectious disease (COVID-19) diagnosis. Methods: 214 confirmed COVID-19 patients who were hospitalized in the General Hospital of Central Theater Command of the People's Liberation Army between January 18 and February 26, 2020, were recruited. Two Enzyme-Linked Immunosorbent Assay (ELISA) kits based on recombinant SARS-CoV-2 nucleocapsid protein (rN) and spike protein (rS) were used for detecting IgM and IgG antibodies, and their diagnostic feasibility was evaluated. Results: Among the 214 patients, 146 (68.2%) and 150 (70.1%) were successfully diagnosed with the rN-based IgM and IgG ELISAs, respectively; 165 (77.1%) and 159 (74.3%) were successfully diagnosed with the rS-based IgM and IgG ELISAs, respectively. The positive rates of the rN-based and rS-based ELISAs for antibody (IgM and\/or IgG) detection were 80.4% and 82.2%, respectively. The sensitivity of the rS-based ELISA for IgM detection was significantly higher than that of the rN-based ELISA. We observed an increase in the positive rate for IgM and IgG with an increasing number of days post-disease onset (d.p.o.), but the positive rate of IgM dropped after 35 d.p.o. The positive rate of rN-based and rS-based IgM and IgG ELISAs was less than 60% during the early stage of the illness 0-10 d.p.o., and that of IgM and IgG was obviously increased after 10 d.p.o. Conclusions: ELISA has a high sensitivity, especially for the detection of serum samples from patients after 10 d.p.o, it can be an important supplementary method for COVID-19 diagnosis.","rel_num_authors":12,"rel_authors":[{"author_name":"Wanbing Liu","author_inst":"Beijing Institute of Microbiology and Epidemiology"},{"author_name":"Lei Liu","author_inst":"Beijing Institute of Microbiology and Epidemiology, Beijing 100071, China"},{"author_name":"Guomei Kou","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Yaqiong Zheng","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Yinjuan Ding","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Wenxu Ni","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Qiongshu Wang","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Li Tan","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Wanlei Wu","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Shi Tang","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Zhou Xiong","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Shangen Zheng","author_inst":"General Hospital of Central Theater Command of PLA, Wuhan, Hubei, China"},{"author_name":"Alexander Kolykhalov","author_inst":"Emory University"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"allergy and immunology"},{"rel_doi":"10.1101\/2020.03.15.20032870","rel_title":"GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY","rel_date":"2020-03-20","rel_site":"medRxiv","rel_link":"https:\/\/medrxiv.org\/cgi\/content\/short\/2020.03.15.20032870","rel_abs":"This report describes the isolation, the molecular characterization and the phylogenetic analysis of the first three complete genomes of SARS-CoV-2 isolated from three patients involved in the first outbreak of COVID-19 in Lombardy, Italy. Early molecular epidemiological tracing suggests that SARS-CoV-2 was present in Italy weeks before the first reported cases of infection.","rel_num_authors":13,"rel_authors":[{"author_name":"Gianguglielmo Zehender","author_inst":"University of Milan"},{"author_name":"Alessia Lai","author_inst":"University of Milan"},{"author_name":"Annalisa Bergna","author_inst":"University of Milan"},{"author_name":"Luca Meroni","author_inst":"III Division of Infectious Diseases, Luigi Sacco Hospital, Milan"},{"author_name":"Agostino Riva","author_inst":"III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Luigi Sacco Hospital, Milan, Italy"},{"author_name":"Claudia Balotta","author_inst":"University of Milan"},{"author_name":"Maciej Tarkowski","author_inst":"University of Milan"},{"author_name":"Arianna Gabrieli","author_inst":"University of Milan"},{"author_name":"Dario Bernacchia","author_inst":"III Division of Infectious Diseases, Luigi Sacco Hospital, Milan, Italy"},{"author_name":"Stefano Rusconi","author_inst":"University of Milan"},{"author_name":"Giuliano Rizzardini","author_inst":"Department of Infectious Diseases, Luigi Sacco Hospital, Milan"},{"author_name":"Spinello Antinori","author_inst":"University of Milan"},{"author_name":"Massimo Galli","author_inst":"University of Milan"},{"author_name":"George Painter","author_inst":"Emory University"},{"author_name":"Ronald Swanstrom","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Kenneth Dinnon III","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Rachel Graham","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Jennifer Harcourt","author_inst":"Centers for Disease Control"},{"author_name":"Azaibi Tamin","author_inst":"Centers for Disease Control"},{"author_name":"Natalie J. Thornburg","author_inst":"Centers for Disease Control and Prevention"},{"author_name":"Stephanie A. Montgomery","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"James Chappell","author_inst":"Vanderbilt University"},{"author_name":"Mark Denison","author_inst":"Vanderbilt University"},{"author_name":"Ralph S. Baric","author_inst":"University of North Carolina at Chapel Hill"},{"author_name":"Merve Cakir","author_inst":"UCSF"},{"author_name":"Michael J. McGregor","author_inst":"UCSF"},{"author_name":"Qiongyu Li","author_inst":"UCSF"},{"author_name":"Zun Zar Chi Naing","author_inst":"UCSF"},{"author_name":"Yuan Zhou","author_inst":"UCSF"},{"author_name":"Shiming Peng","author_inst":"UCSF"},{"author_name":"Ilsa T. Kirby","author_inst":"UCSF"},{"author_name":"James E. Melnyk","author_inst":"UCSF"},{"author_name":"John S Chorba","author_inst":"UCSF"},{"author_name":"Kevin Lou","author_inst":"UCSF"},{"author_name":"Shizhong A. Dai","author_inst":"UCSF"},{"author_name":"Wenqi Shen","author_inst":"UCSF"},{"author_name":"Ying Shi","author_inst":"UCSF"},{"author_name":"Ziyang Zhang","author_inst":"UCSF"},{"author_name":"Inigo Barrio-Hernandez","author_inst":"EMBL-EBI"},{"author_name":"Danish Memon","author_inst":"EMBL-EBI"},{"author_name":"Claudia Hernandez-Armenta","author_inst":"EMBL-EBI"},{"author_name":"Christopher J.P. Mathy","author_inst":"UCSF"},{"author_name":"Tina Perica","author_inst":"UCSF"},{"author_name":"Kala B. Pilla","author_inst":"UCSF"},{"author_name":"Sai J. Ganesan","author_inst":"UCSF"},{"author_name":"Daniel J. Saltzberg","author_inst":"UCSF"},{"author_name":"Rakesh Ramachandran","author_inst":"UCSF"},{"author_name":"Xi Liu","author_inst":"UCSF"},{"author_name":"Sara B. Rosenthal","author_inst":"University of California San Diego"},{"author_name":"Lorenzo Calviello","author_inst":"UCSF"},{"author_name":"Srivats Venkataramanan","author_inst":"UCSF"},{"author_name":"Jose Liboy-Lugo","author_inst":"UCSF"},{"author_name":"Yizhu Lin","author_inst":"UCSF"},{"author_name":"Stephanie A. Wankowicz","author_inst":"UCSF"},{"author_name":"Markus Bohn","author_inst":"UCSF"},{"author_name":"Phillip P. Sharp","author_inst":"UCSF"},{"author_name":"Raphael Trenker","author_inst":"UCSF"},{"author_name":"Janet M. Young","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Devin A. Cavero","author_inst":"UCSF"},{"author_name":"Joseph Hiatt","author_inst":"UCSF"},{"author_name":"Theo Roth","author_inst":"UCSF"},{"author_name":"Ujjwal Rathore","author_inst":"UCSF"},{"author_name":"Advait Subramanian","author_inst":"UCSF"},{"author_name":"Julia Noack","author_inst":"UCSF"},{"author_name":"Mathieu Hubert","author_inst":"Institut Pasteur"},{"author_name":"Ferdinand Roesch","author_inst":"Institut Pasteur"},{"author_name":"Thomas Vallet","author_inst":"Institut Pasteur"},{"author_name":"Bj\u00f6rn Meyer","author_inst":"Institut Pasteur"},{"author_name":"Kris M. White","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Lisa Miorin","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Oren S. Rosenberg","author_inst":"UCSF"},{"author_name":"Kliment A. Verba","author_inst":"UCSF"},{"author_name":"David Agard","author_inst":"UCSF"},{"author_name":"Melanie Ott","author_inst":"UCSF"},{"author_name":"Michael Emerman","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Davide Ruggero","author_inst":"UCSF"},{"author_name":"Adolfo Garc&iacute-Sastre","author_inst":"Icahn School of Medicine at Mount Sinai"},{"author_name":"Natalia Jura","author_inst":"UCSF"},{"author_name":"Mark von Zastrow","author_inst":"UCSF"},{"author_name":"Jack Taunton","author_inst":"UCSF"},{"author_name":"Alan Ashworth","author_inst":"UCSF"},{"author_name":"Olivier Schwartz","author_inst":"Institut Pasteur"},{"author_name":"Marco Vignuzzi","author_inst":"Institut Pasteur"},{"author_name":"Shaeri Mukherjee","author_inst":"UCSF"},{"author_name":"Matt Jacobson","author_inst":"UCSF"},{"author_name":"Harmit S. Malik","author_inst":"Fred Hutchinson Cancer Research Center"},{"author_name":"Danica G Fujimori","author_inst":"UCSF"},{"author_name":"Trey Ideker","author_inst":"University of California San Diego"},{"author_name":"Charles S Craik","author_inst":"UCSF"},{"author_name":"Stephen Floor","author_inst":"UCSF"},{"author_name":"James S. Fraser","author_inst":"UCSF"},{"author_name":"John Gross","author_inst":"UCSF"},{"author_name":"Andrej Sali","author_inst":"UCSF"},{"author_name":"Tanja Kortemme","author_inst":"UCSF"},{"author_name":"Pedro Beltrao","author_inst":"EMBL-EBI"},{"author_name":"Kevan Shokat","author_inst":"UCSF"},{"author_name":"Brian K. Shoichet","author_inst":"UCSF"},{"author_name":"Nevan J. Krogan","author_inst":"QBI COVID-19 Research Group (QCRG); University of California San Francisco, Quantitative Biosciences Institute (QBI); J. David Gladstone Institutes"}],"version":"1","license":"cc_by_nc_nd","type":"PUBLISHAHEADOFPRINT","category":"epidemiology"}]}



